3 Biotech Stocks That Surged Last Week
Dozens of healthcare stocks grew by double-digit percentages last week, and shares of these three drugmakers rose further than nearly all of their peers. Clinical trial results, coronavirus vaccine progress, and a buyout were the major factors that turned these biotech stocks into big gainers last week.
Want to know more about what produced these monstrous gains? Read on to see why the market drove these stocks through the roof.